Fresenius SE Net Income 2016-2023 | FSNUY

Fresenius SE annual/quarterly net income history and growth rate from 2016 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Fresenius SE net income for the quarter ending September 30, 2023 was $-0.442B, a 236.68% decline year-over-year.
  • Fresenius SE net income for the twelve months ending September 30, 2023 was $0.268B, a 84.83% decline year-over-year.
  • Fresenius SE annual net income for 2022 was $1.446B, a 32.79% decline from 2021.
  • Fresenius SE annual net income for 2021 was $2.151B, a 10.31% increase from 2020.
  • Fresenius SE annual net income for 2020 was $1.95B, a 7.54% decline from 2019.
Fresenius SE Annual Net Income
(Millions of US $)
2022 $1,446
2021 $2,151
2020 $1,950
2019 $2,109
2018 $2,392
2017 $2,050
2016 $1,763
2015 $1,507
Fresenius SE Quarterly Net Income
(Millions of US $)
2023-09-30 $-442
2023-06-30 $87
2023-03-31 $371
2022-12-31 $251
2022-09-30 $323
2022-06-30 $408
2022-03-31 $463
2021-12-31 $572
2021-09-30 $487
2021-06-30 $568
2021-03-31 $524
2020-12-31 $492
2020-09-30 $499
2020-06-30 $453
2020-03-31 $506
2019-12-31 $571
2019-09-30 $494
2019-06-30 $529
2019-03-31 $515
2018-12-31 $586
2018-09-30 $487
2018-06-30 $778
2018-03-31 $541
2017-12-31 $603
2017-09-30 $465
2017-06-30 $495
2017-03-31 $487
2016-12-31 $478
2016-09-30 $442
2016-06-30 $444
2016-03-31 $399
2015-12-31 $393
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.392B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.26
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
U.S Physical Therapy (USPH) United States $1.516B 39.30
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00